ETON
Price
$64.43
Change
+$0.96 (+1.51%)
Updated
Aug 24 closing price
Capitalization
1.84B
72 days until earnings call
Intraday BUY SELL Signals
FDMT
Price
$15.39
Change
-$0.44 (-2.78%)
Updated
Aug 24 closing price
Capitalization
849.1M
78 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ETON vs FDMT

ETON vs FDMT Comparison Chart in %
View a ticker or compare two or three
VS
ETON vs. FDMT commentary
Aug 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETON is a StrongBuy and FDMT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2026
Stock price -- (ETON: $64.43 vs. FDMT: $15.39)
Brand notoriety: ETON and FDMT are both not notable
ETON represents the Pharmaceuticals: Generic, while FDMT is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETON: 130% vs. FDMT: 121%
Market capitalization -- ETON: $1.84B vs. FDMT: $849.1M
ETON [@Pharmaceuticals: Generic] is valued at $1.84B. FDMT’s [@Biotechnology] market capitalization is $849.1M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $138.79B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETON’s FA Score shows that 1 FA rating(s) are green whileFDMT’s FA Score has 1 green FA rating(s).

  • ETON’s FA Score: 1 green, 4 red.
  • FDMT’s FA Score: 1 green, 4 red.
According to our system of comparison, ETON is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETON’s TA Score shows that 4 TA indicator(s) are bullish while FDMT’s TA Score has 5 bullish TA indicator(s).

  • ETON’s TA Score: 4 bullish, 4 bearish.
  • FDMT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ETON and FDMT are a good buy in the short-term.

Price Growth

ETON (@Pharmaceuticals: Generic) experienced а +4.37% price change this week, while FDMT (@Biotechnology) price change was +5.81% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.06%. For the same industry, the average monthly price growth was +10.15%, and the average quarterly price growth was +33.23%.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.42%. For the same industry, the average monthly price growth was +8.01%, and the average quarterly price growth was +3182.41%.

Reported Earning Dates

ETON is expected to report earnings on Nov 05, 2026.

FDMT is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.06% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Biotechnology (+1.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETON($1.84B) has a higher market cap than FDMT($849M). ETON YTD gains are higher at: 281.017 vs. FDMT (105.200). ETON has higher annual earnings (EBITDA): 6.2M vs. FDMT (-171.62M). FDMT has more cash in the bank: 391M vs. ETON (19.7M). FDMT has less debt than ETON: FDMT (20.5M) vs ETON (31.2M). FDMT (88.2M) and ETON (86.9M) have equivalent revenues.
ETONFDMTETON / FDMT
Capitalization1.84B849M217%
EBITDA6.2M-171.62M-4%
Gain YTD281.017105.200267%
P/E Ratio165.21N/A-
Revenue86.9M88.2M99%
Total Cash19.7M391M5%
Total Debt31.2M20.5M152%
FUNDAMENTALS RATINGS
ETON: Fundamental Ratings
ETON
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
1
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETONFDMT
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ETON
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AZBIX29.90N/A
N/A
Virtus Small-Cap Institutional
FLMAX11.56N/A
N/A
Meeder Muirfield Adviser
NMIDX30.16N/A
N/A
Columbia Large Cap Enhanced Core S
FRVFX54.31-0.33
-0.60%
Franklin Small Cap Value C
RSEBX80.09-0.55
-0.68%
American Funds SMALLCAP World R-2E

ETON and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETON has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ETON jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETON
1D Price
Change %
ETON100%
+1.51%
MDGL - ETON
34%
Loosely correlated
-0.92%
VKTX - ETON
31%
Poorly correlated
-1.95%
ARRY - ETON
30%
Poorly correlated
-2.56%
FDMT - ETON
29%
Poorly correlated
-2.78%
SIGA - ETON
28%
Poorly correlated
-3.29%
More

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with KYTX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-2.78%
KYTX - FDMT
59%
Loosely correlated
-2.14%
RCKT - FDMT
53%
Loosely correlated
+0.57%
PRME - FDMT
51%
Loosely correlated
-4.13%
EDIT - FDMT
51%
Loosely correlated
-3.54%
SLDB - FDMT
51%
Loosely correlated
-1.51%
More